ALTIMMUNE ANNOUNCES DATA FROM RECLAIM PHASE 2 TRIAL OF PEMVIDUTIDE IN ALCOHOL USE DISORDER SELECTED AS LATE-BREAKING ORAL PRESENTATION AT AASLD THE LIVER MEETING® 2026

Reuters · 4d ago

Please log in to view news